|
CEO to President?
Former Forbes 30 under 30 honoree, Vivek Ramaswamy, has officially begun his candidacy for the 2024 Republican Presidential primary by resigning from the Roivant board.
His odds of winning are about as good as the odds of his clutch of 'vant' companies profiting more than he himself raked in spinning all those IPOs & SPACs.
(His first company to IPO – Axovant Sciences, has lost money every year for a total of $835M since they went public, and his most recent company, Roivant, has lost $3.3B in the past four years)
He may actually be a decent, not-too-insane candidate for the GOP, but fat chance primary voters are going to look even a millimeter past the big two names.
Guess if you’re bored, why not shake hands with some farmers in Iowa for a year...they’re pretty nice folks. But gotta be a rough circuit for a vegetarian like Vivek.
Vintage Website
We fell upon this dated website and started the process of seeing how we could rag on them. But as we browsed, we realized that even though it looks bad, it's logically designed, and you can find what you need pretty easily.
More websites should be like that. Guess you can't always judge a website by its cover. Thumbs up, Wilmington!
Two Long
Devyser decided it was important that their company name could easily be slapped onto a personalized license plate, so for their logo they dropped the two E’s and got it down to five letters: DVYSR.
If you were driving by that car, you might think it stood for:
Davey Senior
Davey Seer
Dive? Yessir
Or you might think former college football coach Steve Spurrier was behind the wheel and rockin’ “Da Visor”.
Regular name looks weird. Abbreviated name looks weirder. 3/10
1998 called
Not often we come across an unknown-to-us biotech company founded back when BPG was still in high school, but that happened this week with Sentia Medical. They're working on a peptide for stress-induced diseases.
The explanation for how they kept under the radar for so long lies in the California business registry. According to that source, Sentia filed their initial paperwork in 1998, took a 23-year hiatus, then got things going again in 2021.
They’ve been back on track since then, so we wish them luck and welcome them to the BioPharmGuy directory.
Trial Name
Companies often come up with clever names for their clinical trials. Sometimes too clever. The BMJ did a Christmas article poking fun at them many years ago. But even nowadays you don’t often see the use of hashtags. HistoSonics is blazing that trail with their newly greenlit #HOPE4KIDNEY trial.
That really sounds more like a hashtag to use when trying to find a transplant donor on Instagram. For a kidney cancer trial maybe they coulda went with KIDney Non-invasive Accurate Pulsing.
That would have surely brought the participants running.
Poached Apple
One of our favorite newsletters, MassDevice, had a short headline about Apple hiring a Medtronic executive. Could this portend a big pivot into the medical device space for Big Fruit? Perhaps.
But when we clicked that item, the actual title of the article pointed out it was the Chief of Human Resources.
Not exactly the most medical devicey person in the Medtronic C-suite. Clickbait!
| 
